Cargando…

Risk Factors Associated with Children Missing the Fourth Dose of DTaP Vaccination

BACKGROUND: In 2012, reported pertussis reached the highest number of cases (48,277) in the United States since 1955. OBJECTIVES: Estimate the prevalence of children who missed the fourth dose of DTaP (Diphtheria and Tetanus toxoids and acellular Pertussis vaccine) by parents’ confidences in vaccine...

Descripción completa

Detalles Bibliográficos
Autor principal:	Zhao, Zhen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181954/ https://www.ncbi.nlm.nih.gov/pubmed/32337176 http://dx.doi.org/10.9734/BJMMR/2015/16117

Ejemplares similares

Improving childhood vaccination coverage rates: the case of fourth dose of DTaP
por: Clark, Sarah J., et al.
Publicado: (2020)

Incomplete Early Childhood Immunization Series and Missing Fourth DTaP Immunizations; Missed Opportunities or Missed Visits?
por: Robison, Steve G.
Publicado: (2012)

Comparing the pertussis antibody levels of healthy children immunized with four doses of DTap-IPV/Hib (Pentaxim) combination vaccine and DTaP vaccine in Quzhou, China
por: Yin, Zhiying, et al.
Publicado: (2023)

The Immunogenicity and Safety of a Combined DTaP-IPV//Hib Vaccine Compared with Individual DTaP-IPV and Hib (PRP~T) Vaccines: a Randomized Clinical Trial in South Korean Infants
por: Kang, Jin Han, et al.
Publicado: (2016)

2698. Timing of Standalone Vaccine Administration in Infants Receiving DTaP-Based Combination Vaccines
por: Alemayehu, Berhanu, et al.
Publicado: (2019)

Mixing of diphtheria, tetanus, and acellular pertussis (DTaP) vaccines in a population of children in managed care
por: Masseria, Cristina, et al.
Publicado: (2015)

Myelin oligodendrocyte glycoprotein antibody-associated disease following DTaP vaccination: A case report
por: Zhang, Xin
Publicado: (2022)

Timing of Monovalent Vaccine Administration in Infants Receiving DTaP-based Combination Vaccines in the United States
por: Marshall, Gary S., et al.
Publicado: (2022)

BCG vaccination improves DTaP immune responses in mice and is associated with lower pertussis incidence in ecological epidemiological studies
por: Broset, Esther, et al.
Publicado: (2021)

DTaP-IPV-HepB-Hib Vaccine (Hexyon(®)): An Updated Review of its Use in Primary and Booster Vaccination
por: Syed, Yahiya Y.
Publicado: (2019)

1393. Factors Associated with Co-administration of Pentavalent DTaP-IPV/Hib and Monovalent Hepatitis B Vaccine in the United States (US)
por: Petigara, Tanaz, et al.
Publicado: (2020)

Dose-Sparing Intradermal DTaP-sIPV Immunization With a Hollow Microneedle Leads to Superior Immune Responses
por: Zuo, Weilun, et al.
Publicado: (2021)

1388. DTaP-containing combination vaccines use and adherence to the recommended infant-toddler vaccination series among privately insured children in the US
por: Loiacono, Matthew M, et al.
Publicado: (2020)

Correction to: DTaP‑IPV‑HepB‑Hib Vaccine (Hexyon(®)): An Updated Review of its Use in Primary and Booster Vaccination
por: Syed, Yahiya Y.
Publicado: (2019)

Safety and immunogenicity of a fully-liquid DTaP-IPV-Hib-HepB vaccine (Vaxelis™) in premature infants
por: Wilck, Marissa B., et al.
Publicado: (2020)

Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination
por: Dowling, David J., et al.
Publicado: (2022)

Effectiveness of DTaP Against Pertussis in ≤2-Year-Old Children — Linyi Prefecture, Shandong Province, China, 2017–2019
por: Zhu, Pinpin, et al.
Publicado: (2023)

A Phase I study to evaluate safety and tolerability of DTaP-IPV + Hib vaccine in healthy adult volunteers in India
por: Sharma, Hitt, et al.
Publicado: (2023)

Mucosal Immunization with DTaP Confers Protection against Bordetella pertussis Infection and Cough in Sprague-Dawley Rats
por: Hall, Jesse M., et al.
Publicado: (2021)

Genetic Variation in the Magnitude and Longevity of the IgG Subclass Response to a Diphtheria-Tetanus-Acellular Pertussis (DTaP) Vaccine in Mice
por: Mosley, Yung-Yi C., et al.
Publicado: (2019)

Post-marketing surveillance to assess the safety and tolerability of a combined diphtheria, tetanus, acellular pertussis and inactivated poliovirus vaccine (DTaP-IPV) in Korean children
por: Lee, Soon Min, et al.
Publicado: (2019)

Simultaneous vaccination with MMR and DTaP-IPV-Hib and rate of hospital admissions with any infections: A nationwide register based cohort study
por: Sørup, Signe, et al.
Publicado: (2016)

Post-Marketing Surveillance of Tetravalent Diphtheria-Tetanus-Acellular Pertussis and Inactivated Poliovirus (DTaP-IPV) Vaccine in South Korea, 2009 to 2015
por: Choe, Young June, et al.
Publicado: (2022)

Guillain Barré syndrome after combined diphtheria, tetanus, and acellular pertussis (DTaP) vaccine: A rare pediatric case report and review of literature
por: Pan, Meichen, et al.
Publicado: (2023)

Immunogenicity and safety of concomitant administration of the chinese inactivated poliovirus vaccine with the diphtheria-tetanus-acellular pertussis (DTaP) vaccine in children: A multicenter, randomized, non-inferiority, controlled trial
por: Sun, Xiang, et al.
Publicado: (2022)

2702. Infants Vaccinated with a Fully-Liquid DTaP-IPV-Hib-HepB Vaccine Are Protected During the High-Risk Period for Haemophilus Influenzae Type B Disease
por: Wilck, Marissa B, et al.
Publicado: (2019)

Concomitant administration of diphtheria, tetanus, acellular pertussis and inactivated poliovirus vaccine derived from Sabin strains (DTaP-sIPV) with pentavalent rotavirus vaccine in Japanese infants
por: Tanaka, Yoshiyuki, et al.
Publicado: (2017)

Demonstration of durable hepatitis B immune memory in children vaccinated with a DTaP5-IPV-HepB-Hib infant-toddler series 7 to 8 years previously
por: Ahonen, Anitta, et al.
Publicado: (2022)

Post-Marketing Safety Surveillance of a Childhood Pentavalent Diphtheria–Tetanus–Acellular Pertussis–Polio and Haemophilus influenzae Type B (DTaP-IPV//Hib) Vaccine in South Korea
por: Yang, Kuhyun, et al.
Publicado: (2022)

Persistence of hepatitis B immune memory until 9–10 years of age following hepatitis B vaccination at birth and DTaP-IPV-HB-PRP∼T vaccination at 2, 4 and 6 months
por: Kosalaraksa, Pope, et al.
Publicado: (2018)

1089 Safety and Immunogenicity of DTaP-IPV (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliovirus Vaccine) Compared to DAPTACEL(®) (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed) + IPOL(®) (Poliovirus Vaccine Inactivated) as the 5th Dose in Children 4 to 6 Years of Age
por: Smith, Michael, et al.
Publicado: (2014)

A second dose of a measles-mumps-rubella vaccine administered to healthy four-to-six-year-old children: a phase III, observer-blind, randomized, safety and immunogenicity study comparing GSK MMR and MMR II with and without DTaP-IPV and varicella vaccines co-administration
Publicado: (2019)

Dental Technologists Association (DTA)
Publicado: (2021)

1112 A Phase III Study of the Safety, Tolerability and Immunogenicity of an Investigational Combination Vaccine against Diphtheria, Tetanus, Pertussis (DTaP5), Polio (IPV), Haemophilus influenzae type b (Hib; PRP-OMPC), and Hepatitis B (HepB) in US Infants
por: Marshall, Gary S., et al.
Publicado: (2014)

Fourth dose of COVID-19 vaccines in Israel
por: Burki, Talha Khan
Publicado: (2022)

GANsDTA: Predicting Drug-Target Binding Affinity Using GANs
por: Zhao, Lingling, et al.
Publicado: (2020)

DeepDTA: deep drug–target binding affinity prediction
por: Öztürk, Hakime, et al.
Publicado: (2018)

SAG-DTA: Prediction of Drug–Target Affinity Using Self-Attention Graph Network
por: Zhang, Shugang, et al.
Publicado: (2021)

Modeling DTA by Combining Multiple-Instance Learning with a Private-Public Mechanism
por: Wang, Chunyu, et al.
Publicado: (2022)

Protein DEK and DTA Aptamers: Insight Into the Interaction Mechanisms and the Computational Aptamer Design
por: Dai, Lijun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7him5rj2uksv7npskqud3q95av